Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

被引：0
作者：
Mao-Lu Tian
Yan Shen
Zhao-Lin Sun
Yan Zha
机构：
[1] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Nephrology
[2] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Urology
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Diabetic nephropathy; Pentoxifylline; Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Randomized controlled trails;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 822
页数：7
相关论文
共 93 条
  • [1] Gregg EW(2014)Changes in diabetes-related complications in the United States, 1990–2010 N Engl J Med 370 1514-1523
  • [2] Li Y(1998)Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229-234
  • [3] Wang J(2013)Kidney disease and increased mortality risk in type 2 diabetes J Am Socm Nephrol 24 302-308
  • [4] Haffner SM(1996)Initiation and progression of diabetic nephropathy N Engl J Med 335 1682-1683
  • [5] Lehto S(2012)Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease Kidney Int 2 337-414
  • [6] Rönnemaa T(2014)Standards of medical care in diabetes 2014 Diab Care 37 S14-S80
  • [7] Afkarian M(2003)Regression of microalbuminuria in type 1 diabetes N Engl J Med 348 2285-2293
  • [8] Sachs MC(2012)KDOQI clinical practice guideline for diabetes and CKD: 2012 update Am J Kidney Dis 60 850-886
  • [9] Kestenbaum B(2012)Cardiorenal end points in a trial of aliskiren for type 2 diabetes N Engl J Med 367 2204-2213
  • [10] Parving HH(2013)Combined angiotensin inhibition for the treatment of diabetic nephropathy N Engl J Med 369 1892-1903
12345678910